November 2021
Price: £95 PLUS VAT
Format: DOWNLOADABLE PDF
This conference examined the applications of data in health and social care and discussed measures that can be taken to scale up use, develop best practice guidelines, and support adoption across all levels of the health system.
It took place following the draft NHS X strategy, Data Saves Lives, which aims to improve understanding around data, address barriers to delivery, and develop a new approach to data-sharing following the extensive use of data throughout the pandemic.
As the Government is currently proposing reforms to healthcare to support innovation and integration, this conference was an opportunity to discuss the role of data in addressing key healthcare challenges going forward and what this approach should look like.
We are pleased to have been able to include keynote contributions on:
- Priorities for the future approach to utilising data within healthcare and research - from Dr Ben Goldacre, Lead, Goldacre Review; and Director, The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford
- Scaling up data use across the health system and meeting data infrastructure needs - from Des Holden, Medical Director, Kent Surrey Sussex Academic Health Science Network
- Developing guidelines and best practice for the use of data in healthcare and supporting innovation - from Páll Jónsson, Programme Director, NICE
- Assessing the use of data in the response to the pandemic and what is required to build on this going forward - from Adam Steventon, Director of Data Analytics, Health Foundation
Attendees
Our forums are known for attracting strong interest from policymakers and stakeholders. Places were reserved by parliamentary pass-holders from the House of Commons, and officials from the Cabinet Office; Competition and Markets Authority; the Department for Digital, Culture, Media and Sport; the Department for International Trade; the Department of Health and Social Care; the Food Standards Agency; the Geospatial Commission; the Government Legal Department; the Health and Safety Executive; HM Treasury; the Home Office; the Information Commissioner's Office; the Medicines and Healthcare products Regulatory Agency; the Ministry of Justice; the National Audit Office; the Office for Life Sciences; The Scottish Government; the UK Statistics Authority; and the Welsh Government. Representatives who also attended were from Addleshaw Goddard; Bird & Bird; Boehringer Ingelheim; Bristows; British Heart Foundation; Burges Salmon; Change Grow Live; Coproduce Care; Covington & Burling; DAC Beachcroft; Doctor Care Anywhere; Economist Intelligence Unit; Elemental; Gordons Partnership; Health Information & Quality Authority; Health Research Authority; Healthwatch Bolton; Imperial College London; Institute for Information Industry; King's College London; Lancaster University; Londonwide LMCs; Microsoft; Mills & Reeve; National Institute for Health Research; NHS Resolution; Northern Ireland Social Care Council; Queen Mary University of London; Res Consortium; Roche Diagnostics; Royal College of Paediatrics and Child Health; RQIA; Sanofi; The Association of the British Pharmaceutical Industry; The Chartered Society of Physiotherapy; University of Edinburgh; University of Glasgow; and University of Warwick.
Press passes had been reserved by representatives from APM Health Europe; Health Service Journal; and Infosecurity Magazine.
